Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML

Aptose Provides Corporate Updates

European Hematology Association Congress (EHA 2025)

Jun 12, 2025 • 5:00 pm - 6:15 pm CEST

2025 Annual and Special Meeting of Shareholders

May 27, 2025 • 10:00 am EDT